Yingchang Mi
Tianjin University of Technology(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Inner Mongolia University(CN)National Clinical Research(US)Second Affiliated Hospital of Xi'an Jiaotong University(CN)Institute of Hematology & Blood Diseases Hospital(CN)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments, Acute Lymphoblastic Leukemia research, Myeloproliferative Neoplasms: Diagnosis and Treatment, Retinoids in leukemia and cellular processes
Most-Cited Works
- → Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia(2022)173 cited
- → Homoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trial(2013)158 cited
- → Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia(2020)108 cited
- → Apoptosis in Leukemia Cells Is Accompanied by Alterations in the Levels and Localization of Nucleolin(2003)102 cited
- → TBLR1 fuses to retinoid acid receptor α in a variant t(3;17)(q26;q21) translocation of acute promyelocytic leukemia(2014)66 cited
- → Risk Factors and Outcomes of Antibiotic-resistant Pseudomonas aeruginosa Bloodstream Infection in Adult Patients With Acute Leukemia